Segmentwise Revenue of Abbott Laboratories
Abbott Laboratories Segmentwise Revenue 2016-2021
Amounts are in $millions.
| Segments | 2021 | 2020 | 2019 |
| Pharmaceutical products | $4,718 | $4,303 | $4,486 |
| Nutritional | $8,294 | $7,647 | $7,409 |
| Diagnostics | $15,644 | $10,805 | $7,713 |
| Medical devices | $14,367 | $11,787 | $12,239 |
| Other | $52 | $66 | $57 |
| Total | $43,075 | $34,608 | $31,904 |
In 2021, Abbott's net revenues from diagnostics took a sharp jump compared to the previous year making it the largest segment based on annual net revenues. Its revenues from diagnostics remained $15.64 billion in 2021 compared to $10.8 billion in 2020. The company generated $14.4 billion from medical devices in 2021 compared to $11.8 billion in 2020.
Medical devices is the largest product segment of Abbott Laboratories based on annual net revenues generated followed by diagnostics. In fiscal 2020, the company generated $11,787 million from the sales of medical devices compared to $12,239 million in 2019. It generated $10,805 million in 2020 from diagnostics compared to $12,239 million in 2019.
| Segments/Year | 2018 | 2017 | 2016 |
| Established Pharmaceuticals | $ 4,422 | $ 4,287 | $ 3,859 |
| Nutritionals | $7,229 | $6,925 | $6,899 |
| Diagnostics | $7,495 | $5,616 | $4,813 |
| Cardiovascular and Neuromodulation | $9,437 | $8,911 | $2,896 |
| Other | $1,995 | $1,651 | $2,386 |
| Total | $30,578 | $ 27,390 | $ 20,853 |